Use of axenic media to determine antibiotic efficacy against coxiella burnetii

被引:9
作者
Clay, K. A. [1 ,2 ]
Hartley, M. G. [1 ]
Russell, P. [1 ]
Norville, I. H. [1 ]
机构
[1] Def Sci & Technol Lab, Salisbury, Wilts, England
[2] Royal Ctr Def Med Acad & Res, Acad Dept, Birmingham, W Midlands, England
关键词
Coxiella burnetii; MIC; Axenic; E-test; IN-VITRO SUSCEPTIBILITY; Q-FEVER; DOXYCYCLINE; CIPROFLOXACIN;
D O I
10.1016/j.ijantimicag.2017.08.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The traditional methods of measuring minimum inhibitory concentration (MIC) of antibiotics against Coxiella burnetii are time-consuming and technically difficult. The discovery of axenic media for C. burnetii culture provided an opportunity to determine the feasibility of using both broth dilution and an antimicrobial gradient method (Etest) as a convenient method of measuring MICs. The MICs for a range of antibiotics that have proven or potential use in the treatment of Q fever, namely doxycycline, ciprofloxacin, levofloxacin, moxifloxacin and co-trimoxazole, were measured. It was possible to measure MICs using both microdilution and Etest methods. MICs obtained were comparable to those from other methods. This study demonstrates the potential use of a relatively simple test to measure MIC in an organism that is difficult to culture. (c) 2017 Published by Elsevier B.V.
引用
收藏
页码:806 / 808
页数:3
相关论文
共 16 条
  • [1] Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR
    Boulos, A
    Rolain, JM
    Maurin, M
    Raoult, D
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (02) : 169 - 174
  • [2] Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization
    Dijkstra, F.
    Riphagen-Dalhuisen, J.
    Wijers, N.
    Hak, E.
    van der Sande, M. A. B.
    Morroy, G.
    Schneeberger, P. M.
    Schimmer, B.
    Notermans, D. W.
    van der Hoek, W.
    [J]. EPIDEMIOLOGY AND INFECTION, 2011, 139 (09) : 1332 - 1341
  • [3] Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
    Drusano, GL
    [J]. NATURE REVIEWS MICROBIOLOGY, 2004, 2 (04) : 289 - 300
  • [4] From Q Fever to Coxiella burnetii Infection: a Paradigm Change
    Eldin, Carole
    Melenotte, Clea
    Mediannikov, Oleg
    Ghigo, Eric
    Million, Matthieu
    Edouard, Sophie
    Mege, Jean-Louis
    Maurin, Max
    Raoult, Didier
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2017, 30 (01) : 115 - 190
  • [5] In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin
    Gikas, A
    Spyridaki, I
    Psaroulaki, A
    Kofterithis, D
    Tselentis, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2747 - 2748
  • [6] Q-FEVER IS ABSENT FROM NEW-ZEALAND
    HILBINK, F
    PENROSE, M
    KOVACOVA, E
    KAZAR, J
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1993, 22 (05) : 945 - 949
  • [7] Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
    Jorgensen, James H.
    Ferraro, Mary Jane
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (11) : 1749 - 1755
  • [8] Antimicrobial therapies for Q fever
    Kersh, Gilbert J.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (11) : 1207 - 1214
  • [9] In vitro susceptibility of Coxiella burnetti to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones
    Lever, MS
    Bewley, KR
    Dowsett, B
    Lloyd, G
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (02) : 194 - 196
  • [10] Reevaluation of the Risk of Fetal Death and Malformation After Q Fever
    Million, Matthieu
    Roblot, France
    Carles, Dominiques
    D'Amato, Felicetta
    Protopopescu, Camelia
    Carrieri, Maria Patrizia
    Raoult, Didier
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (02) : 256 - 260